Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Renal Replacement Therapy
Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation.
Adonis
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
New perspectives on developing acute stroke therapy.
See All 23 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New perspectives on developing acute stroke therapy.
Fisher M, Ratan R. New perspectives on developing acute stroke therapy. Ann Neurol. 2003 Jan; 53(1):10-20.
View in:
PubMed
subject areas
Acute Disease
Animals
Fibrinolytic Agents
Humans
Neuroprotective Agents
Stroke
authors with profiles
Marc Fisher MD